People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Recros Medica, Inc. | — | Biotechnology | Series A | $9.9M | $149.0M | 2018 |
Christoph J. Westphal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christoph J. Westphal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David F Hale | 1 | 16 |
| Kathleen D. Scott | 1 | 5 |
| Thomas A. Albright | 1 | 2 |
| Cathy L. McCarthy | 1 | 1 |
| Milind K. Ambe, M.D. | 1 | 1 |
| Mark J. Kerslake | 1 | 1 |
| Edward F. Knowlton, M.D. | 1 | 1 |
| Cathy F. McCarthy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.